ClinicalTrials.gg

Telavant, Inc. clinical trials

Acquired by Hoffmann-La Roche, Dec 14, 2023 · source ↗

The registry lists 4 studies whose lead sponsor is Telavant, Inc. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 23, 2023.

Before and after it joined Hoffmann-La Roche

First submitted before Telavant, Inc. became part of Hoffmann-La Roche
4
First submitted after Telavant, Inc. became part of Hoffmann-La Roche
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Telavant, Inc.’s studies test, most studies first; none is open now — 1 drug with a page of their own. Each count opens the studies in search.

Studies, none open

All 4 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Completed375%
  • Stopped early125%

Phase

  • Phase 22
  • Phase 12

Where

  • United States2
  • Korea, Republic of1
  • Poland1
  • Belgium1
  • Italy1
  • Netherlands1

Over the years

  1. 113
  2. 14
  3. 15
  4. 16
  5. 17
  6. 18
  7. 19
  8. 20
  9. 21
  10. 22
  11. 23
  12. 24
  13. 25
  14. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Telavant, Inc.4 studies

Something wrong with this grouping? Tell us on the Hoffmann-La Roche page.

Studies

Recruiting first, then most recently updated. Showing 4 of 4. All Hoffmann-La Roche studies →